Using wearable and PRO check-ins for relapsed myeloma
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study uses your self-reported symptoms (PRO) and wearable/device data to help improve care for people with relapsed multiple myeloma who are starting new treatment. It may help by providing insights about how you’re doing during therapy—without changing your cancer treatment in a study-specific way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have confirmed multiple myeloma, and your doctor at the study site agrees
- You are starting at least your second treatment for multiple myeloma, and you’ve already tried a proteasome inhibitor and/or an immune-modulating drug
- Your doctor does not think you are likely to live 6 months or less, and you are not on comfort-only care
- You can read/speak enough English for the study, and you can use a smartphone or device for texting/email/mobile apps
- You have not previously joined Pack Health digital health coaching, and you’re not in a treatment study that would prevent joining this one
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial follows people with multiple myeloma who are getting isatuximab through a vein (IV). It tests how well real-world health tracking (text/app messages and Fitbit data) works during treatment, and whether it can help care teams understand your experience.
This study tests whether remote monitoring and health coaching can improve quality of life in older adults with multiple myeloma who are experiencing fatigue. You'll use a tablet or smartphone to track symptoms and get support from a coach.
This trial tests a digital app designed to help people with multiple myeloma (a blood cancer) manage their quality of life and symptoms. The study wants to see if using this app on a phone or computer can help patients feel better and stay connected to their care.
This study checks how well remote (at-home) symptom check-ins work for people with certain cancers. It may help patients and clinicians spot problems earlier and improve day-to-day care during treatment and beyond.
This trial enrolls people with multiple myeloma who are starting (or have recently started) standard drug treatment, so researchers can collect real-world information about patients’ experiences and outcomes. It may help by improving future care planning and study designs, while adding an extra set of questionnaires to your routine.
This trial tests if a wearable device paired with a smartphone app can help monitor symptoms in cancer survivors. The goal is to improve how we track and manage symptoms during and after treatment.
Hear when a new Multiple myeloma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.